Following her presentation, we caught up with Dr Nives Pustišek (Children’s Hospital Zagreb, Croatia) to discuss current treatment goals in atopic dermatitis.
Her talk entitled ‘Treatment strategies in 2021: Atopic Dermatitis’ was presented at the EADV Spring Symposium, 6-7 May 2021.
Disclosures: Dr Nives Pustišek has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.
Filmed as a highlight of EADV Spring Symposium 2021 (Virtual).
Share this Video
Related Videos In Atopic Dermatitis
Kim Papp, AAD VMX 2021: Ruxolitinib Phase 3 Subgroup Analysis
It was a pleasure to speak with Dr Kim Papp (Probity Medical Research, Waterloo, ON, Canada) around the efficacy and tolerability of ruxolitinib cream in the treatment of atopic dermatitis (NCT03745638 & NCT03745651). The abstract ‘Efficacy of Ruxolitinib Cream for the Treatment of Atopic Dermatitis by Baseline Clinical Characteristics: Pooled Subgroup Analysis From Two Randomized […]
Amy S. Paller, AAD VMX: Dupilumab LIBERTY AD PEDS Trial
We were delighted to speak with Prof. Amy S. Paller (Northwestern University Feinberg School of Medicine, Chicago, IL, USA) about the results from the phase 3, LIBERTY AD PEDS trial (NCT03345914). This double-blind, 16-week study investigated duplimuab in children with atopic dermatitis. Her abstract entitled ‘Dupilumab Provides Clinically Meaningful Improvement in Atopic Dermatitis (AD) Signs, […]
Amy S. Paller, AAD VMX: Advances in the Treatment of Atopic Dermatitis in Children
Following the AAD VMX meeting we caught up with Prof. Amy S. Paller (Northwestern University Feinberg School of Medicine, Chicago, IL, USA) to discuss some of the presentations and recent advances being made in the treatment of children with atopic dermatitis. Disclosures: Prof. Amy Paller has acted as a consultant with honorarium for AbbVie, Abeona, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!